Hadjipanayis C.G. et al. used bioconjugates of anti-epidermal growth factor receptor (EGFR) deletion mutant antibody with iron oxide nanoparticles (EGFRvIIIAb–IONPs) for targeted imaging and therapeutic treatment of glioblastoma [92]. This evidence concerns the gene EGFR and glioblastoma.